IRCT138904014236N1
Effect of Topiramate in treatment of chronic schizophrenia
Effectiveness of Topiramate augmentation compared with placebo in chronic schizophrenia admitted to Ebnesina and Hejaze Hospitals in Mashad
Mashad university of medical sciences·Iranian Registry Of Clinical Trial·biologicalCompleted
Study focus
- Disease/Condition
- Schizophrenia
- Study type
- Interventional
- Intervention type
- biological
Sponsor & location
- Primary sponsor
- Mashad university of medical sciences
- Location
- Iran
Timeline & enrollment
- Phase
- N/A
- Start date
- Mar 21, 2006
- End date
- N/A
ICD-10 classifications
SchizophreniaSimple schizophreniaSchizophrenia, unspecifiedOther schizophreniaParanoid schizophrenia
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT138904014236N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT138904014236N1 through Pure Global AI's free database. This phase not specified trial is sponsored by Mashad university of medical sciences and is currently Completed. The study focuses on Schizophrenia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.